05 Apr 2013, BioSpectrum Bureau , BioSpectrum
Singapore: VolitionRx, a life sciences company focused on developing blood-based diagnostic tests, hired Dr Jason Terrell as head of US operations. Dr Terrell will initially be responsible for facilitating Volition's entry into the US market, acting as the company's FDA liaison and pursuing and negotiating FDA compliant US clinical trials.
Dr Terrell has a strong grounding in both medicine and more specifically in diagnostics. He currently owns and operates a number of diagnostic laboratories in Texas within the 'Any Lab Test Now' franchise, a direct access lab testing company, and has also served as a national franchise corporate medical director for Any Lab Test Now, giving him oversight of over 70 franchises in 14 states.
Dr Terrell was educated at Houston Medical School, University of Texas. He undertook his general medicine internship and anatomic and clinical pathology residency at Texas Tech University Health Sciences Center. Dr Terrell holds medical licences in 14 states across the US.
VolitionRx CEO, Mr Cameron Reynolds, said that, "It is extremely important for us to have a strong focus on the US as the world's largest, and the single most important, healthcare market. We could not be happier that Dr Terrell has agreed to join Volition. He has significant experience both as a doctor and in senior roles within several healthcare diagnostic businesses, giving him a unique insight into both the medical and business perspectives."
Dr Jason Terrell said that, "VolitionRx has great potential, and its technology promises to revolutionize cancer diagnostics and save countless lives. The science and management team have done a truly remarkable job, and I look forward to helping them move towards FDA approval and US rollout of their blood tests for a range of cancers."